Growth Metrics

Rigel Pharmaceuticals (RIGL) Enterprise Value Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -35.73%
Dec 31, 2025 -38.59%
Sep 30, 2025 -18.87%
Jun 30, 2025 -6.72%
Mar 31, 2025 10.49%
Dec 31, 2024 14.79%
Sep 30, 2024 24.70%
Jun 30, 2024 31.59%
Mar 31, 2024 -7.99%
Dec 31, 2023 0.23%
Sep 30, 2023 5.04%
Jun 30, 2023 11.39%
Mar 31, 2023 15.12%
Dec 31, 2022 15.96%
Sep 30, 2022 8.76%
Jun 30, 2022 7.42%
Mar 31, 2022 5.63%
Dec 31, 2021 0.93%
Sep 30, 2021 -7.37%
Jun 30, 2021 -4.35%
Mar 31, 2021 25.28%
Dec 31, 2020 20.88%
Sep 30, 2020 -2.27%
Jun 30, 2020 -3.97%
Mar 31, 2020 0.76%
Dec 31, 2019 -9.47%
Sep 30, 2019 -8.03%
Jun 30, 2019 -5.78%
Mar 31, 2019 -7.27%
Dec 31, 2018 -0.59%
Sep 30, 2018 4.88%
Jun 30, 2018 2.12%
Mar 31, 2018 16.36%
Dec 31, 2017 6.84%
Sep 30, 2017 24.42%
Jun 30, 2017 22.39%
Mar 31, 2017 20.51%
Dec 31, 2016 29.35%
Sep 30, 2016 28.26%
Jun 30, 2016 27.74%
Mar 31, 2016 27.54%
Dec 31, 2015 24.91%
Sep 30, 2015 9.94%
Jun 30, 2015 10.77%
Mar 31, 2015 10.30%
Dec 31, 2014 16.70%
Sep 30, 2014 15.96%
Jun 30, 2014 14.24%
Mar 31, 2014 -96.62%
Dec 31, 2013 -6.14%
Sep 30, 2013 -118.75%
Jun 30, 2013 -98.39%